Literature DB >> 6128245

Modulation of dopaminergic transmission by alpha-noradrenergic agonists and antagonists: evidence for antidopaminergic properties of some alpha antagonists.

P C Waldmeier, R Ortmann, S Bischoff.   

Abstract

Mesh：

Substances：

Year:  1982        PMID： 6128245     DOI： 10.1007/bf01959727

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


× No keyword cloud information.
  27 in total

1.  Pre- and postsynaptic effects of yohimbine stereoisomers on noradrenergic transmission in the pulmonary artery of the rabbit.

Authors:  R Weitzell; T Tanaka; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-08       Impact factor: 3.000

2.  High selectivity of rauwolscine for presynaptic alpha-adrenoceptors.

Authors:  T Tanaka; R Weitzell; K Starke
Journal:  Eur J Pharmacol       Date:  1978-11-15       Impact factor: 4.432

3.  The effects of agents acting at pre- and postsynaptic alpha-adrenoceptors on haloperidol catalepsy [proceedings].

Authors:  J Brown; S L Handley
Journal:  Br J Pharmacol       Date:  1979-07       Impact factor: 8.739

4.  On the relevance of preferential increases of mesolimbic versus striatal dopamine turnover for the prediction of antipsychotic activity of psychotropic drugs.

Authors:  P C Waldmeier; L Maître
Journal:  J Neurochem       Date:  1976-08       Impact factor: 5.372

5.  Depression of exploratory activity by clonidine in rats as a model for the detection of relative pre- and postsynaptic central noradrenergic receptor selectivity of alpha-adrenolytic drugs.

Authors:  A Delini-Stula; P Baumann; O Büch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-06       Impact factor: 3.000

6.  Different alpha-adrenoreceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents.

Authors:  N E Andén; M Grabowska; U Strömbom
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000

7.  Serotoninergic modulation of mesolimbic and frontal cortical dopamine neurons.

Authors:  P C Waldmeier
Journal:  Experientia       Date:  1980-09-15

8.  Anomalous properties of [3H]spiperone binding sites in various areas of the rat limbic system.

Authors:  D R Howlett; H Morris; S R Nahorski
Journal:  Mol Pharmacol       Date:  1979-05       Impact factor: 4.436

9.  Regional rat brain levels of 3,4-dihydroxyphenylacetic acid and homovanillic acid: concurrent fluorometric measurement and influence of drugs.

Authors:  B H Westerink; J Korf
Journal:  Eur J Pharmacol       Date:  1976-08       Impact factor: 4.432

10.  Catecholamine receptor agonists: effects on motor activity and rate of tyrosine hydroxylation in mouse brain.

Authors:  U Strömbom
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000
View more
  7 in total

1.  Alpha 1- and alpha 2-adrenoreceptor antagonists differentially influence locomotor and stereotyped behaviour induced by d-amphetamine and apomorphine in the rat.

Authors:  S L Dickinson; B Gadie; I F Tulloch
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

2.  Presynaptic regulation of the electrically evoked release of endogenous dopamine from the isolated neurointermediate lobe or isolated neural lobe of the rat pituitary gland in vitro.

Authors:  K Racké; A Grosshans; S Sirrenberg; K Ziegler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-05       Impact factor: 3.000

3.  Antagonism of the behavioral effects of cocaine and d-amphetamine by prazosin.

Authors:  R E Tessel; J E Barrett
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

4.  Presynaptic alpha 2A-adrenoceptors inhibit the release of endogenous dopamine in rabbit caudate nucleus slices.

Authors:  A U Trendelenburg; K Starke; N Limberger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-11       Impact factor: 3.000

5.  Dose-response relationship for oral idazoxan effects in healthy human subjects: comparison with oral yohimbine.

Authors:  J H Krystal; C J McDougle; S W Woods; L H Price; G R Heninger; D S Charney
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

6.  Pharmacological profile of a new potent and specific alpha 2-adrenoceptor antagonist, L-657,743.

Authors:  D J Pettibone; B V Clineschmidt; V J Lotti; J J Baldwin; J R Huff; W C Randall; J Vacca; S D Young
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-08       Impact factor: 3.000

7.  The effectiveness of yohimbine in blocking rat central dopamine autoreceptors in vivo.

Authors:  J C van Oene; J B de Vries; A S Horn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-10       Impact factor: 3.000
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.